These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

632 related items for PubMed ID: 14502240

  • 1. M-CSF, TNFalpha and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase.
    Glantschnig H, Fisher JE, Wesolowski G, Rodan GA, Reszka AA.
    Cell Death Differ; 2003 Oct; 10(10):1165-77. PubMed ID: 14502240
    [Abstract] [Full Text] [Related]

  • 2. Activin A stimulates IkappaB-alpha/NFkappaB and RANK expression for osteoclast differentiation, but not AKT survival pathway in osteoclast precursors.
    Sugatani T, Alvarez UM, Hruska KA.
    J Cell Biochem; 2003 Sep 01; 90(1):59-67. PubMed ID: 12938156
    [Abstract] [Full Text] [Related]

  • 3. Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells.
    Yang CR, Wang JH, Hsieh SL, Wang SM, Hsu TL, Lin WW.
    Cell Death Differ; 2004 Jul 01; 11 Suppl 1():S97-107. PubMed ID: 15002040
    [Abstract] [Full Text] [Related]

  • 4. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction.
    Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Morinaga T, Higashio K, Martin TJ, Suda T.
    J Exp Med; 2000 Jan 17; 191(2):275-86. PubMed ID: 10637272
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.
    Xing L, Bushnell TP, Carlson L, Tai Z, Tondravi M, Siebenlist U, Young F, Boyce BF.
    J Bone Miner Res; 2002 Jul 17; 17(7):1200-10. PubMed ID: 12096833
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function.
    Jimi E, Akiyama S, Tsurukai T, Okahashi N, Kobayashi K, Udagawa N, Nishihara T, Takahashi N, Suda T.
    J Immunol; 1999 Jul 01; 163(1):434-42. PubMed ID: 10384146
    [Abstract] [Full Text] [Related]

  • 9. Interleukin-7 is a direct inhibitor of in vitro osteoclastogenesis.
    Lee SK, Kalinowski JF, Jastrzebski SL, Puddington L, Lorenzo JA.
    Endocrinology; 2003 Aug 01; 144(8):3524-31. PubMed ID: 12865334
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of osteoclast differentiation and bone resorption by a novel lysophosphatidylcholine derivative, SCOH.
    Kwak HB, Lee SW, Li YJ, Kim YA, Han SY, Jhon GJ, Kim HH, Lee ZH.
    Biochem Pharmacol; 2004 Apr 01; 67(7):1239-48. PubMed ID: 15013839
    [Abstract] [Full Text] [Related]

  • 11. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P, Tu Q, Chen J.
    J Bone Miner Res; 2005 Sep 01; 20(9):1669-79. PubMed ID: 16059638
    [Abstract] [Full Text] [Related]

  • 12. Psoralen and Bakuchiol Ameliorate M-CSF Plus RANKL-Induced Osteoclast Differentiation and Bone Resorption Via Inhibition of AKT and AP-1 Pathways in Vitro.
    Chai L, Zhou K, Wang S, Zhang H, Fan N, Li J, Tan X, Hu L, Fan X.
    Cell Physiol Biochem; 2018 Sep 01; 48(5):2123-2133. PubMed ID: 30110702
    [Abstract] [Full Text] [Related]

  • 13. Activation of osteoclasts by interleukin-1: divergent responsiveness in osteoclasts formed in vivo and in vitro.
    Fox SW, Fuller K, Chambers TJ.
    J Cell Physiol; 2000 Sep 01; 184(3):334-40. PubMed ID: 10911364
    [Abstract] [Full Text] [Related]

  • 14. Tumor necrosis factor-alpha supports the survival of osteoclasts through the activation of Akt and ERK.
    Lee SE, Chung WJ, Kwak HB, Chung CH, Kwack KB, Lee ZH, Kim HH.
    J Biol Chem; 2001 Dec 28; 276(52):49343-9. PubMed ID: 11675379
    [Abstract] [Full Text] [Related]

  • 15. Beta-cryptoxanthin stimulates apoptotic cell death and suppresses cell function in osteoclastic cells: change in their related gene expression.
    Uchiyama S, Yamaguchi M.
    J Cell Biochem; 2006 Aug 01; 98(5):1185-95. PubMed ID: 16514646
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Lipopolysaccharide supports survival and fusion of preosteoclasts independent of TNF-alpha, IL-1, and RANKL.
    Suda K, Woo JT, Takami M, Sexton PM, Nagai K.
    J Cell Physiol; 2002 Jan 01; 190(1):101-8. PubMed ID: 11807816
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.